The Stanford Integrated Psychosocial Assessment for transplantation, healthcare utilization, and adverse medical events for 3years post-kidney transplantation

2015 ◽  
Vol 78 (6) ◽  
pp. 634
Author(s):  
P. Zimbrean ◽  
Patron-Lozano ◽  
N. Edgington ◽  
M. Joyce ◽  
C. Gaffney ◽  
...  
2020 ◽  
Vol 7 ◽  
pp. 205435812094721
Author(s):  
Benjamin Mappin-Kasirer ◽  
Lawrence Hoffman ◽  
Shaifali Sandal

Rationale: New-onset psychosis in an immunosuppressed patient post-kidney transplantation (KT) is a diagnostic challenge. A broad differential diagnosis merits consideration; however, an approach to this differential diagnosis remains to be outlined in the literature. Also, when and how to modify the maintenance immunosuppressive regimen remains a significant area of controversy. Presenting concerns: A 23-year-old male, known for X-linked Alport syndrome for which he had undergone KT 1 year prior, presented with a 1-week history of disorganized speech, bizarre behavior, religious delusions, and visual hallucinations. Diagnoses: After ruling out infectious, metabolic, autoimmune, and structural causes, immunosuppressant medications were changed from tacrolimus to cyclosporine. The patient did not improve after this change, and a second opinion consultation with a transplant psychiatrist led to a diagnosis of primary first-episode psychosis, later refined to bipolar disorder type I. Interventions: The patient was started on risperidone, which led to a significant improvement in his symptoms. Outcomes: Twelve months after discharge, his mood and behavior had returned to baseline on aripiprazole, bupropion, and citalopram. However, he developed acute allograft rejection, prompting a change from cyclosporine back to tacrolimus, with stability of his mental state and graft function. Teaching points: This report offers learners an extensive and organized differential diagnosis to the work up of psychosis post kidney transplantation. A complete history, with input from collateral sources, and a systematic approach to the differential diagnosis, are crucial and should not be overshadowed by the risk of immunosuppressant-related neurotoxicity. We underscore the importance of multi-disciplinary management and comprehensive psychosocial assessment and re-assessment to refine the diagnosis. We also report the successful re-introduction of tacrolimus once the diagnosis of a primary psychiatric disorder is confirmed. Finally, we offer a simplified approach that can aid in distinguishing between a primary psychiatric diagnosis versus tacrolimus-associated psychosis.


2004 ◽  
Vol 171 (4S) ◽  
pp. 494-494
Author(s):  
Michio Michio Nojima ◽  
Tetsuro Yoshimoto ◽  
Atsushi Nakao ◽  
Takuo Maruyama ◽  
Hidekazu Takiuchi ◽  
...  

2004 ◽  
Vol 171 (4S) ◽  
pp. 491-492
Author(s):  
William C. Nahas ◽  
Paulo R. Gianini ◽  
Luiz B. Saldanha ◽  
Eduardo Mazzucchi ◽  
Joannis Antonopoulos ◽  
...  

2004 ◽  
Vol 171 (4S) ◽  
pp. 515-515
Author(s):  
Felipe G. Balbontin ◽  
Bryce Kiberd ◽  
Philip Belitsky ◽  
Dharm Singh ◽  
Albert Fraser ◽  
...  

2013 ◽  
Vol 32 (9) ◽  
pp. 1013-1022 ◽  
Author(s):  
Kyle M. Clayton ◽  
Sunita M. Stewart ◽  
Deborah J. Wiebe ◽  
Charles E. McConnel ◽  
Carroll W. Hughes ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document